Table 1.
Demographic characteristics of study participants at baseline and after 4 years of MDA (post‐MDA group)
| Characteristic | Baseline (n = 210) | Post‐MDA Group (n = 251) | |
|---|---|---|---|
| Male sex, n (%) | 102 (48.6) | 131 (52.2) | |
| Age (years), median | 15 | 15 | |
| Schistosoma mansoni egg count: arithmetic mean (95% CI) of S. mansoni‐positive individuals, epg | 160 (126‐ 193) | 29 (11‐ 46) | |
| Proportion with S. mansoni infection intensity, n (%) | Negative (0 epg) | 0 (0) | 205 (81.7) |
| Light (1‐99 epg) | 122 (58.1) | 44 (17.5) | |
| Moderate (100‐399 epg) | 70 (33.3) | 2 (0.8) | |
| Heavy (≥400 epg) | 18 (8.6) | 0 (0) | |
| STH prevalence, n (%) | 43 (20.5) | 4 (1.6) | |
| Malaria prevalence, n (%) | 62 (29.8) | 77 (30.7) | |
CI, confidence interval; epg, eggs per gram; STH, soil‐transmitted helminths; MDA, mass drug administration.